Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial

Autor: Penalver, FJ, Marquez, JA, Duran, S, Giraldo, P, Martin, A, Montalban, C, Sancho, JM, Ramirez, MJ, Terol, MJ, Capote, FJ, Gutierrez, A, Sanchez, B, Lopez, A, Salar, A, Rodriguez-Caravaca, G, Canales, M, Caballero, MD, Lopez, JLB, Carbonell, F, Bordas, SF, Lopez, PF, Persona, EP, Guillermo, AL, Martin, RH, Mayans, JR, Palomera, L, Ceballos, EP, Hernandez, JAQ, Grau, RR, de la Cruz, F, Salinas, AS

Publikováno v: Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Cancer medicine
r-FISABIO. Repositorio Institucional de Producción Científica
Cancer Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

Background Consensus is lacking regarding the optimal salvage therapy for patients with follicular lymphoma who relapse after or are refractory to immunochemotherapy. Methods This phase II trial evaluated the efficacy and safety of response-adapted t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::38d0108d847e62c93eac4419133d1794
http://zaguan.unizar.es/record/86474

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Darbepoetin alfa for anemia in patients with low or intermediate-1 risk myelodysplastic syndromes and positive predictive factors of response.

Autor: Villegas A; Hematology Department, Hospital Clínico San Carlos Universidad Complutense, Madrid, Spain. avillegas.hcsc@salud.madrid.org, Arrizabalaga B, Fernández-Lago C, Castro M, Mayans JR, González-Porras JR, Duarte RF, Remacha AF, Luño E, Gasquet JA

Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2011 May; Vol. 27 (5), pp. 951-60. Date of Electronic Publication: 2011 Mar 07.

Outbreak of intra-hospital acquired rotavirus in a pediatric hospital in Mexico.

Autor: Santibáñez GS, Mayans JR, Saldaña NG, Orozco HH, Narvaez JL, Aburto EL, Delgadillo NN, Viveros WD, Olguín HJ

Publikováno v: Salud publica de Mexico [Salud Publica Mex] 2009 Mar-Apr; Vol. 51 (2), pp. 96.

ZAP-70 mRNA expression provides clinically valuable information in early-stage chronic lymphocytic leukemia.

Autor: Reinoso-Martín C, Jantus-Lewintre E, Ballesteros CG, Campos CB, Ferrer JR, García-Conde J

Publikováno v: Haematologica [Haematologica] 2008 Sep; Vol. 93 (9), pp. 1422-4.